<div dir="ltr"><div class="gmail_default" style="font-size:large"><br></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">---------- Forwarded message ---------<br>From: <span dir="auto"><<a href="mailto:dlegge@phmovement.org">dlegge@phmovement.org</a>></span><br>Date: Fri, Jan 19, 2024 at 1:43 PM<br></div><br><div class="msg-4557952342745499826"><div bgcolor="#FAFAFA" link="blue" vlink="purple" style="word-wrap:break-word" lang="EN-AU"><div class="m_-4557952342745499826WordSection1"><div align="center"><table style="width:100.0%;background:#fafafa;border-collapse:collapse" width="100%" cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="width:100.0%;padding:7.5pt 7.5pt 7.5pt 7.5pt" width="100%" valign="top"><div align="center"><table style="width:450.0pt;border-collapse:collapse" width="600" cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="width:450.0pt;padding:0cm 0cm 0cm 0cm" width="600" valign="top"><div align="center"><table style="max-width:450.0pt;border-collapse:collapse" cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="background:#fafafa;padding:6.75pt 0cm 6.75pt 0cm" valign="top"><table style="width:100.0%;border-collapse:collapse" width="100%" cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="padding:6.75pt 0cm 0cm 0cm" valign="top"><table style="width:100.0%;border-collapse:collapse" width="100%" cellspacing="0" cellpadding="0" border="0" align="left"><tbody><tr><td style="width:450.0pt;padding:0cm 0cm 0cm 0cm" width="600" valign="top"><table style="width:100.0%;border-collapse:collapse" width="100%" cellspacing="0" cellpadding="0" border="0" align="left"><tbody><tr><td style="padding:0cm 13.5pt 6.75pt 13.5pt" valign="top"><p class="MsoNormal" style="text-align:center" align="center"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif;color:#656565"><a href="https://mailchi.mp/phmovement/eb154-09_immunisation-17630405?e=5f3cea0f3e" target="_blank"><span style="color:#656565">View this email in your browser</span></a><u></u><u></u></span></p></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><td style="background:white;padding:6.75pt 0cm 0cm 0cm;background:cover;background-size:cover" id="m_-4557952342745499826templateHeader" valign="top"><table style="width:100.0%;border-collapse:collapse;min-width:100%" width="100%" cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="padding:6.75pt 6.75pt 6.75pt 6.75pt;min-width:100%" valign="top"><table style="width:100.0%;border-collapse:collapse" width="100%" cellspacing="0" cellpadding="0" border="0" align="left"><tbody><tr><td style="padding:0cm 6.75pt 0cm 6.75pt;min-width:100%" valign="top"><p class="MsoNormal" style="text-align:center" align="center"><img style="width:5.875in;height:3.2083in" id="m_-4557952342745499826_x0000_i1026" src="https://mcusercontent.com/559d715f58f654accf3de987e/images/0b1bd6d2-85d4-c0fe-ef58-a4a1ab9cc235.jpg" width="564" height="308" border="0"><u></u><u></u></p></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><td style="border:none;border-bottom:solid #eaeaea 1.5pt;background:white;padding:0cm 0cm 6.75pt 0cm;background:cover;background-size:cover" id="m_-4557952342745499826templateBody" valign="top"><table style="width:100.0%;border-collapse:collapse;min-width:100%" width="100%" cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="padding:6.75pt 0cm 0cm 0cm;min-width:100%" valign="top"><table style="width:100.0%;border-collapse:collapse" width="100%" cellspacing="0" cellpadding="0" border="0" align="left"><tbody><tr><td style="width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width:100%" width="600" valign="top"><table style="width:100.0%;border-collapse:collapse;word-break:break-word" width="100%" cellspacing="0" cellpadding="0" border="0" align="left"><tbody><tr><td style="padding:0cm 13.5pt 6.75pt 13.5pt" valign="top"><h1 style="text-align:center" align="center">Funding for ‘neglected tropical diseases’ (NTDs) has collapsed since the Covid pandemic <u></u><u></u></h1><p class="MsoNormal" style="margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif;color:#202020">Members of WHO’sExecutive Board meeting in Geneva next week will consider a new report (<a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=491eaf0eec&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">EB154/11</span></a>) which documents the “rapid decrease in funding to combat NTDs”. The report states that this is now the most urgent barrier to progress. The erosion of the funding base for NTDs is among the most important of the issues for the Executive Board’s discussion, as it represents a clear waste of previous financial commitments and a prolongation of the suffering of nearly one billion people from diseases with known preventions and treatments. The coverage of preventive chemotherapy has sharply decreased in the wake of the Covid pandemic.<br><br>WHO’s member states must decide if NTDs are to be continued to be neglected with insufficient resources or if WHO is to be supported with sufficient funding to implement the NTD Road Map.<br><br>The report describes a medicines regime which depends on pharmaceutical partners to expand donations. This may work where elimination is an immediate goal, but in most cases, this is not sustainable and not a substitute to affordable local manufacture and procurement. It is also uncertain whether appeals to big pharma is going to be enough to direct new investment into innovations of new medicines or new combinations of existing medicines.  In some NTDs, such as snake-bite both diagnosis and care is based on approaches which are close to a century old. The global intellectual property rights regime and the dependence of drug development funding on monopoly (IPR protected) profit is not generating the next generation of diagnostic tools and medicines to prevent and respond to NTDs.<br><br>The latest report does not address the wider social determinants of NTDs, including urban development, water management, and occupational health and worker rights. Conflict, drought and migration are also emerging threats to the control / elimination of NTDs but are not addressed in the report. However, each NTD has its own set of proximate and intermediate determinants and addressing these require planned action at both the primary care and the community level, as well as intersectoral action. These cannot be constructed as 21 vertical programmes. The need is to build successful models for addressing NCDs which is fully integrated within equitable development and comprehensive primary healthcare.<br><br>PHM urges member States to:<u></u><u></u></span></p><ol type="1" start="1"><li class="MsoNormal" style="color:#202020"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif">Support WHO with resources necessary to enable the elimination of all 21 NTDs by 2030;<u></u><u></u></span></li><li class="MsoNormal" style="color:#202020"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif">Prioritize social interventions to prevent or address NTDs, alongside chemotherapy and other biomedical interventions;<u></u><u></u></span></li><li class="MsoNormal" style="color:#202020"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif">Focus on ensuring that regional and local plans address each of these 21 diseases where they constitute a public health priority;<u></u><u></u></span></li><li class="MsoNormal" style="color:#202020"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif">Prioritise the integration of NTD programs with strengthened CPHC so that the reductions are sustainable;<u></u><u></u></span></li><li class="MsoNormal" style="color:#202020"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif">Ensure that calls for eradication are supported by evidence of cost-effectiveness and sustainability.<u></u><u></u></span></li></ol></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table><p class="MsoNormal"><u></u> <u></u></p><table style="width:100.0%;border-collapse:collapse;min-width:100%" width="100%" cellspacing="0" cellpadding="0" border="0"><tbody><tr><td style="padding:6.75pt 0cm 0cm 0cm" valign="top"><table style="width:100.0%;border-collapse:collapse" width="100%" cellspacing="0" cellpadding="0" border="0" align="left"><tbody><tr><td style="width:450.0pt;padding:0cm 0cm 0cm 0cm;max-width:100%;min-width:100%" width="600" valign="top"><table style="width:100.0%;border-collapse:collapse;word-break:break-word" width="100%" cellspacing="0" cellpadding="0" border="0" align="left"><tbody><tr><td style="padding:0cm 13.5pt 6.75pt 13.5pt" valign="top"><p class="MsoNormal" style="margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif;color:#202020">The full PHM commentary on this item (<a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=eed67a0718&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">here</span></a>) provides more detail and references. See also Tracker links to <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=107ac0f3cb&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">previous discussions of NTDs</span></a>.<u></u><u></u></span></p><p class="MsoNormal" style="margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif;color:#202020">The WHO Tracker and PHM item commentaries are produced as part of <b><span style="font-family:"Tahoma",sans-serif">WHO Watch</span></b> which is a project of the <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=f6468a49fc&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">People's Health Movement</span></a> in association with <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=8785c24190&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">Medicus Mundi International</span></a>, <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=0be257f21b&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">Third World Network</span></a> and a number of other civil society networks. WHO Watch contributes to democratising global health governance, through new alliances, new information flows and by broadening the policy discourse.<u></u><u></u></span></p><p class="MsoNormal" style="margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif;color:#202020">See the WHO Tracker page for this EB154 session (<a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=b234cd59b9&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">here</span></a>). See PHM’s <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=0d06b91d09&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">integrated commentary</span></a> on the full agenda of EB154 (or read the <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=f91d2d9af7&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">flipbook version</span></a>). To ensure that you receive Update Alerts <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=a5bcf8a2ed&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">subscribe</span></a> to the Updater. <br><br>You can support WHO Watch by forwarding this Item Alert, by publicising the <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=512a2e308e&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">Tracker</span></a>, by inviting others to <a href="https://phmovement.us20.list-manage.com/track/click?u=559d715f58f654accf3de987e&id=ee0f9f49be&e=5f3cea0f3e" target="_blank"><span style="color:#007c89">subscribe to GHG Reports</span></a>; and by following us on social media via @PHMglobal and @WorldHealthWatch.<u></u><u></u></span></p><p class="MsoNormal" style="margin-right:0cm;margin-bottom:7.5pt;margin-left:0cm"><span style="font-size:9.0pt;font-family:"Tahoma",sans-serif;color:#202020">To provide feedback on this newsletter please write to <a href="mailto:editor@phmovement.org" target="_blank"><span style="color:#007c89">editor@phmovement.org</span></a>.<u></u><u></u></span></p></td></tr></tbody></table></td></tr></tbody></table></td></tr></tbody></table></td></tr><tr><td style="background:#fafafa;padding:6.75pt 0cm 6.75pt 0cm;background:cover;background-size:cover" id="m_-4557952342745499826templateFooter" valign="top"><p class="MsoNormal"><u></u> <u></u></p></td></tr></tbody></table></div></td></tr></tbody></table></div></td></tr></tbody></table></div><p class="MsoNormal"><img style="width:.0104in;height:.0104in" id="m_-4557952342745499826_x0000_i1025" src="https://phmovement.us20.list-manage.com/track/open.php?u=559d715f58f654accf3de987e&id=530641a7f1&e=5f3cea0f3e" width="1" height="1" border="0"><u></u><u></u></p></div></div>_______________________________________________<br>
g2h2-members mailing list -- <a href="mailto:g2h2-members@g2h2.org" target="_blank">g2h2-members@g2h2.org</a><br>
To unsubscribe send an email to <a href="mailto:g2h2-members-leave@g2h2.org" target="_blank">g2h2-members-leave@g2h2.org</a><br>
</div></div></div>